Back
Denali Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
DNLI
Denali Therapeutics, Inc.
Last Price:
$16.43
Seasonality Move:
-10.73%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight selling pressure.
Denali Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.89 | Sell |
| 20-day SMA: | 17.84 | Sell |
| 50-day SMA: | 17.23 | Sell |
| 200-day SMA: | 15.07 | Buy |
| 8-day EMA: | 17 | Sell |
| 20-day EMA: | 17.4 | Sell |
| 50-day EMA: | 17.09 | Sell |
| 200-day EMA: | 16.66 | Sell |
Denali Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 42.61 | Sell |
| Chaikin Money Flow: | -510994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.92 - 19.22) | Sell |
| Bollinger Bands (100): | (14.25 - 17.67) | Buy |
Denali Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics, Inc. Stock
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 16.58 while DNLI 8-day simple moving average is 16.89, which is a Sell signal.
-
The stock price of DNLI is 16.58 while Denali Therapeutics, Inc. 20-day SMA is 17.84, which makes it a Sell.
-
Denali Therapeutics, Inc. 50-day simple moving average is 17.23 while DNLI share price is 16.58, making it a Sell technically.
-
DNLI stock price is 16.58 and Denali Therapeutics, Inc. 200-day simple moving average is 15.07, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Buy
57
Denali Therapeutics, Inc. (DNLI)
is a Buy
Is Denali Therapeutics, Inc. a Buy or a Sell?
-
Denali Therapeutics, Inc. stock is rated a BuyThe current Denali Therapeutics, Inc. [DNLI] share price is $16.58. The Score for DNLI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Denali Therapeutics, Inc. Stock Info
Market Cap:
2.6B
Price in USD:
16.58
Share Volume:
1.3M
Denali Therapeutics, Inc. 52-Week Range
52-Week High:
24.35
52-Week Low:
10.57
Buy
57
Denali Therapeutics, Inc. (DNLI)
is a Buy
Denali Therapeutics, Inc. Share Price Forecast
-
What is the Denali Therapeutics, Inc. stock price today?The Denali Therapeutics, Inc. stock price is 16.58 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics, Inc. is not overvalued.
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 16.58 while DNLI 8-day exponential moving average is 17.00, which is a Sell signal.
-
The stock price of DNLI is 16.58 while Denali Therapeutics, Inc. 20-day EMA is 17.40, which makes it a Sell.
-
Denali Therapeutics, Inc. 50-day exponential moving average is 17.09 while DNLI share price is 16.58, making it a Sell technically.
-
DNLI stock price is 16.58 and Denali Therapeutics, Inc. 200-day simple moving average is 16.66, creating a Sell signal.
Fundamental Analysis of Denali Therapeutics, Inc.
Is Denali Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.04 per share.
Technical Analysis of Denali Therapeutics, Inc.
Should I short Denali Therapeutics, Inc. stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Denali Therapeutics, Inc. is a Sell
-
Denali Therapeutics, Inc. Relative Strength Index (RSI) is 42.61, which suggest Denali Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Denali Therapeutics, Inc. is (16.92 - 19.22), which suggest Denali Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Denali Therapeutics, Inc. is (14.25 - 17.67), which suggest Denali Therapeutics, Inc. is a Buy
* Denali Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.